Innate immune responses in NF-kappaB-repressing factor-deficient mice

Mol Cell Biol. 2006 Jan;26(1):293-302. doi: 10.1128/MCB.26.1.293-302.2006.

Abstract

NF-kappaB-repressing factor (NRF) is a transcriptional silencer protein that specifically counteracts the basal activity of several NF-kappaB-dependent promoters by direct binding to specific neighboring DNA sequences. In cell culture experiments, the reduction of NRF mRNA leads to a derepression of beta interferon, interleukin-8, and inducible nitric oxide synthase transcription. The X chromosome-located single-copy NRF gene is ubiquitously expressed and encodes a protein of 690 amino acids. The N-terminal part contains a nuclear localization signal, the DNA-binding domain, and the NF-kappaB-repressing domain, while the C-terminal part is responsible for double-stranded RNA binding and nucleolar localization. To study the function of NRF in a systemic context, transgenic mice lacking the NRF gene were created. Against predictions from in vitro experiments, mice with a deletion of the NRF gene are viable and have a phenotype that is indistinguishable from wild-type mice, even after challenge with different pathogens. The data hint towards an unexpected functional redundancy of NRF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Cells / immunology
  • Cell Nucleus / chemistry
  • Disease Susceptibility / immunology
  • Fibroblasts / metabolism
  • Gene Deletion
  • Gene Expression Profiling
  • Immunity, Innate* / genetics
  • Interferon-beta / metabolism
  • Lipopolysaccharides / toxicity
  • Listeria monocytogenes
  • Listeriosis / immunology*
  • Macrophages / drug effects
  • Macrophages / immunology
  • Mice
  • Mice, Knockout
  • NF-kappa B p50 Subunit / analysis
  • NF-kappa B p50 Subunit / genetics
  • NF-kappa B p50 Subunit / metabolism*
  • Nitric Oxide Synthase Type II / metabolism
  • Virus Diseases / immunology*

Substances

  • Lipopolysaccharides
  • NF-kappa B p50 Subunit
  • Nfkb1 protein, mouse
  • Interferon-beta
  • Nitric Oxide Synthase Type II